March Biosciences, Inc.
🇺🇸United States
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)MB-105 in Patients With CD5 Positive T-cell Lymphoma
Phase 2
Recruiting
- Conditions
- Lymphoma, T-Cell
- First Posted Date
- 2024-08-02
- Last Posted Date
- 2025-05-08
- Lead Sponsor
- March Biosciences Inc
- Target Recruit Count
- 46
- Registration Number
- NCT06534060
- Locations
- 🇺🇸
University of San Diego (UCSD)-Moores Cancer Center, San Diego, California, United States
🇺🇸SCRI - Colorado Blood Cancer Institute (CBCI), Denver, Colorado, United States
🇺🇸Moffitt Cancer Center Magnolia Campus, Tampa, Florida, United States
News
No news found